Chromosomal instability (CIN) is a hallmark of cancer, associated with tumor cell malignancy. CIN arises from errors in DNA replication and chromosome segregation during cell division, leading to chromosomal abnormalities. In normal cells, CIN is harmful, causing DNA damage, proteotoxic stress, metabolic changes, cell cycle arrest, and senescence. However, CIN is also a hallmark of over 90% of solid tumors and blood cancers. It can enhance tumor adaptation through increased intratumor heterogeneity, facilitating adaptive resistance to therapies. However, excessive CIN can lead to tumor cell death, highlighting the "just-right" model for CIN in tumors. Understanding CIN is crucial for understanding tumorigenesis and developing effective anti-tumor treatments. CIN manifests in two forms: numerical CIN (aneuploidy, polyploidy) and structural CIN (chromosome segment gain/loss). Numerical CIN results from errors in chromosome segregation, while structural CIN arises from chromosomal rearrangements. These forms often coexist in tumor cells, creating a complex interplay. CIN is linked to tumor evolution, creating genetic diversity and enabling malignant phenotypes and adaptive resistance. It is also associated with metastasis and tumor immune regulation. Despite advancements, our understanding of CIN remains incomplete, necessitating a systematic review. CIN research has evolved over a century, with key milestones including Boveri's work on aneuploidy, the discovery of the Philadelphia chromosome, and the development of CIN mouse models. CIN is linked to cancer progression and is a target for therapy. Recent studies show that CIN can drive tumor metastasis and is associated with various therapeutic strategies. CIN is caused by errors in DNA replication, chromosome segregation, and defects in DNA repair systems. These include replication stress, defects in the SAC, aberrant centrosome number, and microtubule-kinetochore attachment errors. These factors contribute to structural and numerical CIN. The paradox of CIN lies in its dual role: while excessive CIN is harmful, moderate levels can be beneficial. In simpler organisms, moderate CIN can confer advantages in stressful environments. In tumors, CIN can promote tumorigenesis through clonal evolution but also induce cell death, senescence, and anti-tumor immune responses. The "just-right" model suggests that a moderate level of CIN is optimal for tumor progression. CIN's multifaceted impact on tumor biology includes DNA damage, proteotoxic stress, metabolic changes, cell cycle arrest, senescence, metastasis, immune regulation, and drug resistance. Understanding these effects is crucial for developing effective anti-tumor therapies.Chromosomal instability (CIN) is a hallmark of cancer, associated with tumor cell malignancy. CIN arises from errors in DNA replication and chromosome segregation during cell division, leading to chromosomal abnormalities. In normal cells, CIN is harmful, causing DNA damage, proteotoxic stress, metabolic changes, cell cycle arrest, and senescence. However, CIN is also a hallmark of over 90% of solid tumors and blood cancers. It can enhance tumor adaptation through increased intratumor heterogeneity, facilitating adaptive resistance to therapies. However, excessive CIN can lead to tumor cell death, highlighting the "just-right" model for CIN in tumors. Understanding CIN is crucial for understanding tumorigenesis and developing effective anti-tumor treatments. CIN manifests in two forms: numerical CIN (aneuploidy, polyploidy) and structural CIN (chromosome segment gain/loss). Numerical CIN results from errors in chromosome segregation, while structural CIN arises from chromosomal rearrangements. These forms often coexist in tumor cells, creating a complex interplay. CIN is linked to tumor evolution, creating genetic diversity and enabling malignant phenotypes and adaptive resistance. It is also associated with metastasis and tumor immune regulation. Despite advancements, our understanding of CIN remains incomplete, necessitating a systematic review. CIN research has evolved over a century, with key milestones including Boveri's work on aneuploidy, the discovery of the Philadelphia chromosome, and the development of CIN mouse models. CIN is linked to cancer progression and is a target for therapy. Recent studies show that CIN can drive tumor metastasis and is associated with various therapeutic strategies. CIN is caused by errors in DNA replication, chromosome segregation, and defects in DNA repair systems. These include replication stress, defects in the SAC, aberrant centrosome number, and microtubule-kinetochore attachment errors. These factors contribute to structural and numerical CIN. The paradox of CIN lies in its dual role: while excessive CIN is harmful, moderate levels can be beneficial. In simpler organisms, moderate CIN can confer advantages in stressful environments. In tumors, CIN can promote tumorigenesis through clonal evolution but also induce cell death, senescence, and anti-tumor immune responses. The "just-right" model suggests that a moderate level of CIN is optimal for tumor progression. CIN's multifaceted impact on tumor biology includes DNA damage, proteotoxic stress, metabolic changes, cell cycle arrest, senescence, metastasis, immune regulation, and drug resistance. Understanding these effects is crucial for developing effective anti-tumor therapies.